Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England

Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England

Gema Requena,1 Alexandrosz Czira,1 Victoria Banks,2 Robert Wood,2 Theo Tritton,2 Catherine Castillo,2 Jie Yeap,2 Rosie Wild,2 Chris Compton,1 Kieran J Rothnie,1 Felix JF Herth,3 Jennifer K Quint,4 Afisi S Ismaila5,6 1GSK, R&D Global Medical, Brentford, Middlesex, UK; 2Real-World Evidence, Adelph...

Full description

Bibliographic Details
Main Authors: Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo C, Yeap J, Wild R, Compton C, Rothnie KJ, Herth FJ, Quint JK, Ismaila AS
Format: Article
Language:English
Published: Dove Medical Press 2023-09-01
Series:International Journal of COPD
Subjects:
copd dual therapy
laba/lama new users
healthcare resource utilization
exacerbations
comparative effectiveness
single-inhaler dual therapy
Online Access:https://www.dovepress.com/comparative-effectiveness-of-umeclidiniumvilanterol-versus-indacaterol-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/comparative-effectiveness-of-umeclidiniumvilanterol-versus-indacaterol-peer-reviewed-fulltext-article-COPD

Similar Items